Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

New England Journal of Medicine · 2005 · 1.6K citations · Full text

Medicine, Gynecology, Obstetrics +9

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Jaime L. Masferrer, K. Leahy, Alane Koki et al. · PubMed · 2000 · 1.3K citations

Medicine, Oncology, Pharmacology +16

Assessment of response to therapy in advanced breast cancer

J.L. Hayward, Paul P. Carbone, J C Heusen et al. · British Journal of Cancer · 1977 · 706 citations · Full text

Medicine, Oncology, Breast Oncology +10

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

Manfred Kaufmann, Emilio Bajetta, Luc Dirix et al. · Journal of Clinical Oncology · 2000 · 525 citations

Medicine, Oncology, Pharmacology +14

Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance

Rachel Schiff, Suleiman Massarweh, Jiang Shou et al. · Clinical Cancer Research · 2004 · 465 citations

Medicine, Endocrinology, Oncology +14